Nuvalent Inc vs SkyWest Inc — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while SkyWest Inc trades at $95.26 (market cap $3.94B). The key difference: Nuvalent Inc is far larger — about 2.5× SkyWest Inc's market cap, and Nuvalent Inc is trading nearer its 52-week high, SkyWest Inc nearer its low. Which is the better fit depends on your goals.
| NUVL | SKYW | |
|---|---|---|
Market Cap | $9.81B | $3.94B |
Sector | Technology | Technology |
52-Week High | $123.96 | $123.72 |
52-Week Low | $72.16 | $78.40 |
Enterprise Value | $8.52B | $5.79B |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →SkyWest, Inc. is a major North American regional airline company, operating primarily through its subsidiary, SkyWest Airlines. The company provides regional airline service to various large airlines under contract, including United Airlines (as United Express), Delta Air Lines (as Delta Connection), American Airlines (as American Eagle), and Alaska Airlines (as Alaska SkyWest). SKYW's primary business is providing essential flight services, connecting smaller cities to major airline hubs across the United States.
Read more on SKYW →